Most patients see a 5 to 8% total body weight loss over 12 months
Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD, Bouillon R
Retrieved July 10th, 2024 from Novo Nordisk (n.d.)
16 CPAP therapyeither standalone or in combination with anti-obesity medications such as GLP-1s for weight losscan be more effective for patients with comorbid obesity if they can lose weight in any healthy, sustainable way
2024;22(9):1847-1857.e11
The Pivot to False Advertising (Lanham Act) Instead of arguing You stole our invention, companies like Novo Nordisk and Eli Lilly are arguing You are lying to patients. The Argument: By marketing a compounded drug as Semaglutide or Generic Ozempic, the pharmacy is deceiving the consumer because the compounded version lacks FDA approval, safety data, and often uses a salt form (Semaglutide Sodium) rather than the approved base